Cipla Limited
Cipla Limited appears in FDA public data with 3 recalls, 0 510(k) clearances, 35 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0197-2026, Class II) was initiated on October 31, 2025.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 35
- Compliance Actions
- 2
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0197-2026 | Class II | Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Ci | October 31, 2025 |
| D-0382-2019 | Class II | Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. V | December 14, 2018 |
| D-1078-2015 | Class III | Levalbuterol Inhalation Solution, USP, 0.31 mg/ 3 mL, 3 mL Vials, Rx Only. Manufactured by: Cipla Lt | April 24, 2015 |